6 assets in Systemic-Onset Juvenile Idiopathic Arthritis

Therapeutic assets addressing Systemic-Onset Juvenile Idiopathic Arthritis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region) Systemic-Onset Juvenile Idiopathic Arthritis	Novartis Pharmaceuticals	P3	BB (64)
Alemtuzumab Systemic-Onset Juvenile Idiopathic Arthritis	Paul Szabolcs	P2	CCC (53)
Fludarabine Systemic-Onset Juvenile Idiopathic Arthritis	Paul Szabolcs	P2	CCC (53)
Hydroxyurea Systemic-Onset Juvenile Idiopathic Arthritis	Paul Szabolcs	P2	CCC (53)
Melphalan Systemic-Onset Juvenile Idiopathic Arthritis	Paul Szabolcs	P2	CCC (53)
Thiotepa Systemic-Onset Juvenile Idiopathic Arthritis	Paul Szabolcs	P2	CCC (53)